• It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

ADMA Biologics: "This is a very speculative situation...Any time there's immunity compromised patients, there's some big money down the road."

MP Materials: "This is one of those situations that is very difficult...If they don't pull out of the tailspin of losses, then it just doesn't matter."

Delcath Systems: "There's no investing. At this point, it is speculating."

Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.

Disclaimer

Money Report

news 58 mins ago

This Japanese AI unicorn has big plans to use deep learning to fix ‘real-world' problems

news 2 hours ago

Gap CEO unpacks blowout quarter: ‘The progress is real'

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Also on CNBC

• Cramer names four worthwhile stocks that were 'lost in the Nvidia shuffle'
• CEO says CrowdStrike is 'willing and open' to a resolution with Delta
• Salesforce CEO explains how customers use new platform 'Agentforce'

Subscribe to the CNBC YouTube Channel

Morning Squawk Newsletter